Comparison of add-on of leukotriene receptor antagonist vs. long-acting beta2-agonist on FeNO in asthmatic children on regular inhaled budesonide

F. F. Buchvald, H. Bisgaard (Copenhagen, Denmark)

Source: Annual Congress 2002 - Updates of inhalation therapy in children
Session: Updates of inhalation therapy in children
Session type: Poster Discussion
Number: 2736
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. F. Buchvald, H. Bisgaard (Copenhagen, Denmark). Comparison of add-on of leukotriene receptor antagonist vs. long-acting beta2-agonist on FeNO in asthmatic children on regular inhaled budesonide. Eur Respir J 2002; 20: Suppl. 38, 2736

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Real-life use and impact of inhaled steroids (ICS) and leukotriene receptor antagonists (LTRA) monotherapy in children with asthma
Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring
Year: 2010

Inhaled corticosteroid combined with long-acting bronchodilator versus long-acting bronchodilator alone for older patients with COPD
Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation
Year: 2015



Triple combination of montelukast or tiotropium and inhaled corticosteroids plus long-acting ß2-agonist in persistent asthma
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018




Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids
Source: Eur Respir J 2016; 48: 558-560
Year: 2016


Can long-acting β2 agonists substitute inhaled corticosteroids in stable persistent asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008


Protective effect of inhaled glucocorticosteroid and long-acting beta2-agonist combination on COPD model
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021

The effect of inhaled corticosteroids in combination with long-acting beta2-agonists in elite athletes with asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009

Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone
Source: Eur Respir J 2003; 21: 123-128
Year: 2003



Short-acting bronchodilator and oral steroid use in asthma patients prescribed either concurrent beclometasone and salmeterol or combined salmeterol/fluticasone
Source: Eur Respir J 2004; 24: Suppl. 48, 309s
Year: 2004

Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Effect of long-acting ß-agonist on bronchodilator response in children with asthma
Source: Eur Respir J, 56 (3) 1902010; 10.1183/13993003.02010-2019
Year: 2020



Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009

Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001

Increased doses of inhaled corticosteroids versus addition of long-acting beta2 agonists for treatment of asthma
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010

Long-acting β2-agonists provide greater benefit compared to leukotriene antagonists when added to inhaled corticosteroids in patients with symptomatic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 310s
Year: 2004

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness
Source: Eur Respir J 2006; 27: 1144-1151
Year: 2006



Low-dose inhaled glucocorticoids are more effective tham LTRA in improving functional data in asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 126s
Year: 2004

Effects of montelukast on tapering inhaled corticosteroids in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002

Effects of montelukast on tapering inhaled corticosteroids in patients with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 260s
Year: 2001

Effects of inhaled corticosteroids on growth in asthmatic children: A comparision of fluticasone propianate with budesonide
Source: Eur Respir J 2003; 22: Suppl. 45, 133s
Year: 2003